DWW-12560-93218 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2023-04-10
Dose 1 — Pfizer-BioNTech
2023-04-11
Registered in v-safe
2023-04-11
Survey response — days 1–6 daily, dose 1, under 3
MedDRA: No adverse event — Feeling: Good · Irritability/crying

MedDRA releases: 2024-11
2023-04-14
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2023-04-17
Survey response — day 7, dose 1, under 3
MedDRA: No adverse event — Feeling: Good · Rash, not including the immediate area around the injection site

MedDRA releases: 2024-11
2023-04-24
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-05-01
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-05-08
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-05-15
Health check-in — day 35, dose 1, under 3
Feeling: Good

Under 3 check-in
2023-05-22
Health check-in — day 42, dose 1, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-04-10	Pfizer-BioNTech	No

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	No adverse event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release